» Articles » PMID: 21412963

Outcomes of Pancreatoduodenectomy with Robotic Surgery Versus Open Surgery

Overview
Journal Int J Med Robot
Publisher Wiley
Date 2011 Mar 18
PMID 21412963
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pancreatoduodenectomy (PD) for pancreatic cancer is very challenging to many surgeons. Information regarding the advantage of using the Da Vinci robotic system over conventional open surgery for PD is rare. Therefore, a comparison of the outcomes of PD performed using the Da Vinci robotic system with outcomes using open surgery was conducted.

Methods: Between January 2009 and December 2009 sixteen patients underwent PD, eight patients receiving robot-assisted surgery using the Da Vinci surgical robotic system (Group I) and eight being treated using conventional open surgery (Group II).

Results: There was no significant difference in radical resection (R0) rate between the two groups, 87.5% vs 100%, P = 0.05. The operative time in group I was longer than in group II, 718 ± 186 vs 420 ± 127 min, P = 0.011, while the surgical blood loss in group I was less than in group II, 153 ± 43 vs 210 ± 53 mL, P = 0.045. The length of bed time and hospital stay after surgery in group I were shorter than in group II, 27.5 ± 7.1 vs 96 ± 18.1 h, P = 0.000; 16.4 ± 4.1 vs 24.3 ± 7.1 days, P = 0.04, respectively). Complication rate of group I was lower than that of group II, 25% vs 75%, P = 0.05.

Conclusion: It is feasible and safe to perform PD using the Da Vinci robot-assisted surgical system; patients recovered faster postoperatively with less blood loss during surgery.

Citing Articles

Robotic versus open pancreatoduodenectomy for periampullary neoplasm: a propensity matched analysis of peri-operative and oncologic outcomes.

Varshney V, Rathore K, Selvakumar B, Soni S, Varshney P, Agarwal L Surg Endosc. 2024; 39(2):922-931.

PMID: 39630267 DOI: 10.1007/s00464-024-11423-4.


Effects of Minimally Invasive Versus Open Pancreatoduodenectomy on Short-Term Surgical Outcomes and Postoperative Nutritional and Immunological Statuses: A Single-Institution Propensity Score-Matched Study.

Yumoto S, Hayashi H, Mima K, Ogawa D, Itoyama R, Kitano Y Ann Surg Open. 2024; 5(3):e487.

PMID: 39310352 PMC: 11415100. DOI: 10.1097/AS9.0000000000000487.


Efficacy and prognostic analysis of carbon nanotracers combined with the da Vinci robot in the treatment of esophageal cancer.

Qi F, Sun Y World J Clin Cases. 2024; 12(22):4924-4931.

PMID: 39109005 PMC: 11238817. DOI: 10.12998/wjcc.v12.i22.4924.


Current progress in robotic hepatobiliary and pancreatic surgery at a high-volume center.

McCarron F, Vrochides D, Martinie J Ann Gastroenterol Surg. 2023; 7(6):863-870.

PMID: 37927925 PMC: 10623982. DOI: 10.1002/ags3.12737.


Short-term outcomes between robot-assisted and open pancreaticoduodenectomy in patients with high body mass index: A propensity score matched study.

Li J, Qian L, Shi Y, Shen B, Peng C Cancer Med. 2023; 12(14):15141-15148.

PMID: 37255405 PMC: 10417296. DOI: 10.1002/cam4.6186.